Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Delayed Nasdaq Other stock markets 16:00:00 2025-02-14 EST			5-day change	1st Jan Change
0.4740 ^USD	-20.74%		-.--%	-

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.35M 2.17M 2.03M 3.79M 259M 3.87M 25.83M 10M 125M 10.16M 9.94M 434M	P/E Ratio 2022	-0.25x	P/E Ratio 2023	-0.19x
Enterprise Value	12.83M 11.13M 10.26M 9.61M 17.96M 1.23B 18.34M 122M 47.39M 592M 48.15M 47.12M 2.06B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
25-02-10	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
25-02-10	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
25-02-10	Avinger, Inc. Announces Executive Changes	CI
24-12-24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24-12-24	US Futures Tread Water Ahead of Holiday Break	MT
24-12-23	Iberdrola Completes Merger with Avangrid	MT
24-11-07	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-11-07	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
24-11-07	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
24-11-07	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
24-10-04	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

23-04-21	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
22-05-11	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
22-03-18	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
21-06-29	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

Avinger, Inc. Stock

Stocks

AVGR

US0537348775

Advanced Medical Equipment & Technology

Valuation: Avinger, Inc.

Latest news : Avinger, Inc.

Analysts' recommendations: Avinger, Inc.

Press Releases: Avinger, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Avinger, Inc.

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Income Statement and Estimates

25-01-02	Avinger : Private Placement Form 8 K	PU
24-11-07	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
24-11-07	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
24-11-07	Avinger: Q3 Earnings Snapshot	AQ
24-10-25	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	2024-08-04

Date	Insider	Type	Main position	Quantity	% Market Cap.
25-01-22	Jeffrey Soinski	Sell	Chief Executive Officer	3,690	0.1115%
25-01-22	Himanshu Patel	Sell	Founder	2,215	0.0669%
25-01-22	Nabeel Subainati	Sell	Chief Financial Officer	1,255	0.0379%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER, INC.	-20.74%	-.--%	-.--%	-94.41%	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	+1.46%	+0.57%	-15.10%	-17.97%	13.58B
IRAY GROUP	+1.59%	-10.57%	+81.41%	+12.63%	5.18B
IRADIMED CORPORATION	-1.84%	+1.78%	+59.05%	+99.31%	1.23B
SONOSCAPE MEDICAL CORP.	-1.55%	-2.41%	-42.78%	-68.58%	1.21B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-2.57%	-7.27%	-36.85%	-43.79%	1.18B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	-1.41%	-5.29%	-42.41%	-	928M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	+0.86%	-7.63%	+187.60%	+181.29%	712M
CAPSOVISION, INC.	+4.35%	-3.48%	-	-	344M
FISCHER MEDICAL VENTURES LIMITED	+4.26%	+8.16%	-56.84%	+211.40%	235M
Average	-1.56%	-1.18%	+14.90%	+34.99%	2.46B
Weighted average by Cap.	+0.93%	-2.22%	+11.34%	-0.53%

	2022	2023
Net sales	8.27M 7.18M 6.62M 6.2M 11.59M 792M 11.83M 78.94M 30.56M 382M 31.06M 30.39M 1.33B	7.65M 6.64M 6.12M 5.74M 10.72M 733M 10.94M 73.02M 28.27M 353M 28.73M 28.11M 1.23B
Net income	-17.62M -15.29M -14.1M -13.21M -24.68M -1.69B -25.19M -168M -65.11M -813M -66.16M -64.73M -2.83B	-18.32M -15.9M -14.65M -13.73M -25.66M -1.75B -26.19M -175M -67.68M -846M -68.77M -67.29M -2.94B
Net Debt	1.76M 1.52M 1.4M 1.32M 2.46M 168M 2.51M 16.76M 6.49M 81.05M 6.59M 6.45M 282M	10.12M 8.78M 8.1M 7.59M 14.17M 969M 14.47M 96.57M 37.39M 467M 37.99M 37.17M 1.62B

3 years	0.36	18
5 years	0.36	438
10 years	0.36	1,000,000